163 related articles for article (PubMed ID: 23512194)
1. Low-dose biplanar skeletal survey versus digital skeletal survey in multiple myeloma.
Boutry N; Dutouquet B; Leleu X; Vieillard MH; Duhamel A; Cotten A
Eur Radiol; 2013 Aug; 23(8):2236-45. PubMed ID: 23512194
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).
Gleeson TG; Moriarty J; Shortt CP; Gleeson JP; Fitzpatrick P; Byrne B; McHugh J; O'Connell M; O'Gorman P; Eustace SJ
Skeletal Radiol; 2009 Mar; 38(3):225-36. PubMed ID: 19009290
[TBL] [Abstract][Full Text] [Related]
3. Comparison of radiation dose, workflow, patient comfort and financial break-even of standard digital radiography and a novel biplanar low-dose X-ray system for upright full-length lower limb and whole spine radiography.
Dietrich TJ; Pfirrmann CW; Schwab A; Pankalla K; Buck FM
Skeletal Radiol; 2013 Jul; 42(7):959-67. PubMed ID: 23536038
[TBL] [Abstract][Full Text] [Related]
4. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.
Horger M; Claussen CD; Bross-Bach U; Vonthein R; Trabold T; Heuschmid M; Pfannenberg C
Eur J Radiol; 2005 May; 54(2):289-97. PubMed ID: 15837412
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey.
Princewill K; Kyere S; Awan O; Mulligan M
Cancer Invest; 2013 Mar; 31(3):206-11. PubMed ID: 23406213
[TBL] [Abstract][Full Text] [Related]
6. Whole body radiography for bone survey screening of cancer and myeloma patients.
Mulligan M; Smith S; Talmi D
Cancer Invest; 2008 Nov; 26(9):916-22. PubMed ID: 18608207
[TBL] [Abstract][Full Text] [Related]
7. Extensive skeletal involvement detected by gallium-67 citrate in a patient with multiple myeloma.
Nishiyama H; Morand TM; Seiwert VJ
Clin Nucl Med; 1988 Mar; 13(3):179-81. PubMed ID: 3164262
[TBL] [Abstract][Full Text] [Related]
8. Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).
Zacchino M; Bonaffini PA; Corso A; Minetti V; Nasatti A; Tinelli C; Dore R; Calliada F; Sironi S
Eur Radiol; 2015 Nov; 25(11):3382-9. PubMed ID: 25987427
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma.
Gundesen MT; Asmussen JT; Haukås E; Schubert M; Abildgaard N; Schjesvold F; Lund T
Eur J Haematol; 2022 May; 108(5):423-429. PubMed ID: 35113466
[TBL] [Abstract][Full Text] [Related]
11. Benefits and unexpected artifacts of biplanar digital slot-scanning imaging in children.
Blumer SL; Dinan D; Grissom LE
Pediatr Radiol; 2014 Jul; 44(7):871-82. PubMed ID: 24563147
[TBL] [Abstract][Full Text] [Related]
12. Proposal for a Quantitative
Takahashi MES; Mosci C; Souza EM; Brunetto SQ; Etchebehere E; Santos AO; Camacho MR; Miranda E; Lima MCL; Amorim BJ; de Souza C; Pericole FV; Lorand-Metze I; Ramos CD
Sci Rep; 2019 Nov; 9(1):16429. PubMed ID: 31712729
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
Ippolito D; Talei Franzesi C; Spiga S; Besostri V; Pezzati S; Rossini F; Sironi S
Br J Haematol; 2017 May; 177(3):395-403. PubMed ID: 28233900
[TBL] [Abstract][Full Text] [Related]
14. [Bone disease in multiple myeloma. A study of 237 cases].
Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
[TBL] [Abstract][Full Text] [Related]
15. Subspecialty Second-Opinion in Multiple Myeloma CT: Emphasis on Clinically Significant Lytic Lesions.
Tagliafico AS; Belgioia L; Bonsignore A; Rossi F; Succio G; Bignotti B; Dominietto A
Medicina (Kaunas); 2020 Apr; 56(4):. PubMed ID: 32340143
[No Abstract] [Full Text] [Related]
16. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
[TBL] [Abstract][Full Text] [Related]
18. [Comparison between traditional skeletal radiography and total body bone scintigraphy in the diagnosis of multiple myeloma].
Scutellari PN; Spanedda R; Feggi LM; Calzolari F; Cervi PM
Radiol Med; 1984 May; 70(5):271-6. PubMed ID: 6531460
[TBL] [Abstract][Full Text] [Related]
19. Organ dose and total effective dose of whole-body CT in multiple myeloma patients.
Hemke R; Yang K; Husseini J; Bredella MA; Simeone FJ
Skeletal Radiol; 2020 Apr; 49(4):549-554. PubMed ID: 31612246
[TBL] [Abstract][Full Text] [Related]
20. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
